FOLH1 and prostate cancer: Similarly, another study found that the combination of PSMA PET with MRI performed better than MRI alone, improving sensitivity (89% for combined vs. 76% for MRI alone) without affecting the specificity, especially for diagnosing clinically significant prostate cancer in PI-RADS 3 lesions [33].